Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143


Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.

Rubinstein WS, Acheson LS, O'Neill SM, Ruffin MT 4th, Wang C, Beaumont JL, Rothrock N; Family Healthware Impact Trial (FHITr) Group.

Genet Med. 2011 Nov;13(11):956-65. doi: 10.1097/GIM.0b013e3182241d88.


Familial risk for common diseases in primary care: the Family Healthware Impact Trial.

O'Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT 4th; Family Healthware Impact Trial group.

Am J Prev Med. 2009 Jun;36(6):506-14. doi: 10.1016/j.amepre.2009.03.002.


Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial.

Acheson LS, Wang C, Zyzanski SJ, Lynn A, Ruffin MT 4th, Gramling R, Rubinstein WS, O'Neill SM, Nease DE Jr; Family Healthware Impact Trial (FHITr) Group.

Genet Med. 2010 Apr;12(4):212-8. doi: 10.1097/GIM.0b013e3181d56ae6.


Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial.

Ruffin MT 4th, Nease DE Jr, Sen A, Pace WD, Wang C, Acheson LS, Rubinstein WS, O'Neill S, Gramling R; Family History Impact Trial (FHITr) Group.

Ann Fam Med. 2011 Jan-Feb;9(1):3-11. doi: 10.1370/afm.1197.


Family history assessment: impact on disease risk perceptions.

Wang C, Sen A, Ruffin MT 4th, Nease DE Jr, Gramling R, Acheson LS, O'Neill SM, Rubinstein WS; Family Healthware™ Impact Trial (FHITr) Group.

Am J Prev Med. 2012 Oct;43(4):392-8.


Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial.

Wu RR, Orlando LA, Himmel TL, Buchanan AH, Powell KP, Hauser ER, Agbaje AB, Henrich VC, Ginsburg GS.

BMC Fam Pract. 2013 Aug 6;14:111. doi: 10.1186/1471-2296-14-111.


Developing Family Healthware, a family history screening tool to prevent common chronic diseases.

Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ.

Prev Chronic Dis. 2009 Jan;6(1):A33. Epub 2008 Dec 15.


Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.

Hughes KS, Roche C, Campbell CT, Siegel N, Salisbury L, Chekos A, Katz MS, Edell E.

Breast J. 2003 Jan-Feb;9(1):19-25.


Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care.

Baer HJ, Schneider LI, Colditz GA, Dart H, Andry A, Williams DH, Orav EJ, Haas JS, Getty G, Whittemore E, Bates DW.

J Gen Intern Med. 2013 Jun;28(6):817-24. doi: 10.1007/s11606-013-2338-z. Epub 2013 Jan 31.


Cancer risk assessment: quality and impact of the family history interview.

Murff HJ, Byrne D, Syngal S.

Am J Prev Med. 2004 Oct;27(3):239-45.


Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial.

Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP.

Breast. 2015 Dec;24(6):758-66. doi: 10.1016/j.breast.2015.09.009. Epub 2015 Oct 21.


Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.

Brannon Traxler L, Martin ML, Kerber AS, Bellcross CA, Crane BE, Green V, Matthews R, Paris NM, Gabram SG.

Ann Surg Oncol. 2014 Oct;21(10):3342-7. doi: 10.1245/s10434-014-3921-1. Epub 2014 Jul 22.


Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.

de Geus E, Aalfs CM, Verdam MG, de Haes HC, Smets EM.

Trials. 2014 Mar 20;15:86. doi: 10.1186/1745-6215-15-86.


Protocol for implementation of family health history collection and decision support into primary care using a computerized family health history system.

Orlando LA, Hauser ER, Christianson C, Powell KP, Buchanan AH, Chesnut B, Agbaje AB, Henrich VC, Ginsburg G.

BMC Health Serv Res. 2011 Oct 11;11:264. doi: 10.1186/1472-6963-11-264.


Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting.

Morgan D, Sylvester H, Lucas FL, Miesfeldt S.

Genet Med. 2010 Jan;12(1):25-31. doi: 10.1097/GIM.0b013e3181c60955.


Family history of cancer and colon cancer risk: the Utah Population Database.

Slattery ML, Kerber RA.

J Natl Cancer Inst. 1994 Nov 2;86(21):1618-26. Erratum in: J Natl Cancer Inst 1994 Dec 7;86(23):1802.


Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.

Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH.

Genet Epidemiol. 1993;10(4):235-44.


Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer.

Isaacs C, Peshkin BN, Schwartz M, Demarco TA, Main D, Lerman C.

Breast Cancer Res Treat. 2002 Jan;71(2):103-12.


Hereditary breast and ovarian cancer: what the primary care physician should know.

Khoury-Collado F, Bombard AT.

Obstet Gynecol Surv. 2004 Jul;59(7):537-42. Review.


Permanence of the information given during oncogenetic counseling to persons at familial risk of breast/ovarian and/or colon cancer.

Kwiatkowski F, Dessenne P, Laquet C, Petit MF, Bignon YJ.

Eur J Hum Genet. 2012 Feb;20(2):141-7. doi: 10.1038/ejhg.2011.169. Epub 2011 Sep 21.

Supplemental Content

Support Center